original ) (raw )Assessing Compliance, Tolerability, Safety, and Efficacy to Treatment with Grass Allergy Tablets in 261 Patients with Grass Pollen Rhinoconjunctivitis
Massimo Milani
2013
View PDFchevron_right
Long-term clinical efficacy in grass pollen–induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet
Glenis Scadding
Journal of Allergy and Clinical Immunology, 2010
View PDFchevron_right
Immunologic Effects and Tolerability Profile of In-Season Initiation of a Standardized-Quality Grass Allergy Immunotherapy Tablet: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial in Adults with Grass Pollen–Induced Rhinoconjunctivitis
Hanne Villesen
Clinical Therapeutics, 2011
View PDFchevron_right
Efficacy of Grass Pollen Allergen Sublingual Immunotherapy Tablets for Seasonal Allergic Rhinoconjunctivitis
Antonella Plaia
JAMA Internal Medicine, 2015
View PDFchevron_right
Clinical management, expectations, and satisfaction of patients with moderate to severe allergic rhinoconjunctivitis treated with SQ-standardized grass-allergen tablet under routine clinical practice conditions in Spain
carlos cruz puerto
Clinical and molecular allergy : CMA, 2017
View PDFchevron_right
A phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma
Martin Pedersen
Journal of Negative Results in BioMedicine, 2013
View PDFchevron_right
Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years
ronald dahl
Journal of Allergy and Clinical Immunology, 2008
View PDFchevron_right
Once-daily sublingual allergen-specific immunotherapy improves quality of life in patients with grass pollen-induced allergic rhinoconjunctivitis: A double-blind, randomised study
Sabina Rak
Quality of Life Research, 2007
View PDFchevron_right
Magnitude of efficacy measurements in grass allergy immunotherapy trials is highly dependent on pollen exposure
Harold Nelson
Allergy, 2014
View PDFchevron_right
Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis
Piotr Kuna
Clinical & Experimental Allergy, 2009
View PDFchevron_right
Allergen immunotherapy as a drug: the new deal of grass allergen tablets from clinical trials to current practice
carlo lombardi
European annals of allergy and clinical immunology, 2013
View PDFchevron_right
Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5–grass pollen tablet for seasonal allergic rhinitis
margitta worm
Journal of Allergy and Clinical Immunology, 2007
View PDFchevron_right
Sublingual grass allergen specific immunotherapy: a retrospective study of clinical outcome and discontinuation
Mary Kämpe
Clinical and Molecular Allergy
View PDFchevron_right
Clinical efficacy and safety of preseasonal sublingual immunotherapy with grass pollen carbamylated allergoid in rhinitic patients. A double-blind, placebo-controlled study
Antero Palma-Carlos , Ava Asda
Allergologia et Immunopathologia, 2006
View PDFchevron_right
Budget impact analysis of two immunotherapy products for treatment of grass pollen-induced allergic rhinoconjunctivitis
Jakob Andreasen
ClinicoEconomics and Outcomes Research, 2012
View PDFchevron_right
Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial
Tielin Qin
JAMA, 2017
View PDFchevron_right
Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy
Raffi Bedikian
Journal of Allergy and Clinical Immunology, 2018
View PDFchevron_right
Towards evidence-based medicine in specific grass pollen immunotherapy
Ralph Mösges
Allergy, 2010
View PDFchevron_right
Direct comparison between continuous and coseasonal regimen for sublingual immunotherapy in children with grass allergy: A randomized controlled study
Lucia Caminiti
Pediatric Allergy and Immunology, 2011
View PDFchevron_right
Protocol for a double-blind randomised controlled trial of low dose intradermal grass pollen immunotherapy versus a histamine control on symptoms and medication use in adults with seasonal allergic rhinitis (PollenLITE)
Abdel Douiri
Clinical and translational allergy, 2013
View PDFchevron_right
Design and Recruitment for the GAP Trial, Investigating the Preventive Effect on Asthma Development of an SQ-Standardized Grass Allergy Immunotherapy Tablet in Children with Grass Pollen–Induced Allergic Rhinoconjunctivitis
Erkka Valovirta
Clinical Therapeutics, 2011
View PDFchevron_right
Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis
Sabina Rak
Allergy, 2006
View PDFchevron_right
Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial
Samantha Walker
Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, 2002
View PDFchevron_right
Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challenge
Deborah Phippard
Allergy, 2015
View PDFchevron_right
Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber
Patrick Lemell
Journal of Allergy and Clinical Immunology, 2009
View PDFchevron_right
Evaluation of the adherence to subcutaneous immunotherapy in patients with pollen allergy in usual clinical practice: The CITY study
Begona Soler
Trends in Medicine
View PDFchevron_right
A survey on the perception of allergy specialists about the reimbursed grass pollen tablets for seasonal allergic rhinitis in Italy
Cristoforo Incorvaia
Clinical and molecular allergy : CMA, 2017
View PDFchevron_right
Methodological aspects of a meta-analysis of grass pollen allergen sublingual immunotherapy tablets
Pascal Demoly
The Journal of allergy and clinical immunology, 2016
View PDFchevron_right
Short-term immunotherapy: A prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitis☆☆☆★
Isaak Effendy
Journal of Allergy and Clinical Immunology, 1997
View PDFchevron_right
The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and children
Jacques Hebert
Allergy, Asthma & Clinical Immunology, 2014
View PDFchevron_right
Intradermal Grass Pollen Allergen Immunotherapy for Seasonal Allergy: A Randomized Controlled Trial
Janet Peacock
Journal of Allergy and Clinical Immunology, 2016
View PDFchevron_right